Outcomes of pancreas retransplantation

Transplantation

Volumn 99, Issue 2, 2015, Pages 367-374

  Rudolph, Ehren N ^a   Finger, Erik B ^a   Chandolias, Nikolaos ^a   Kandaswamy, Raja ^a   Sutherland, David E R ^a   Dunn, Ty B ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CYCLOSPORIN; DACLIZUMAB; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ANALYTICAL PARAMETERS; ARTICLE; COLD ISCHEMIA TIME; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH CENSORED GRAFT SURVIVAL; FACTUAL DATABASE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS AFTER KIDNEY TRANSPLANTATION; PANCREAS RETRANSPLANTATION; PANCREAS SURGERY; PANCREATITIS; PATIENT SELECTION; PATIENT SURVIVAL; PEROPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RETRANSPLANTATION; RISK FACTOR; SEX DIFFERENCE; SIMULTANEOUS KIDNEY PANCREAS TRANSPLANTATION; SURGICAL INFECTION; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TECHNICAL FAILURE; THROMBOSIS; TRANSPLANTATION; ADVERSE EFFECTS; GRAFT REJECTION; KAPLAN MEIER METHOD; MORTALITY; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PROCEDURES; REOPERATION; RISK ASSESSMENT; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; DATABASES, FACTUAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MINNESOTA; PANCREAS TRANSPLANTATION; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84922885563     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000566     Document Type: Article

References (24)

1. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery. 1967;61:827-837.
2. Troppmann C. Complications after pancreas transplantation. Curr Opin Organ Transplant. 2010;15:112-118.
3. Sutherland DE, Goetz FC, Elick B, Najarian JS. Experience with 49 segmental pancreas transplants in 45 diabetic patients. Transplantation. 1982;34:330-338.
4. Morel P, Schlumpf R,Dunn DL,Moudry-Munns K,Najarian JS, Sutherland DE. Pancreas retransplants compared with primary transplants. Transplantation. 1991;51:825-833.
5. Stratta RJ, Sindhi R, Taylor JA, et al. Retransplantation in the diabetic with a pancreas allograft after previous kidney or pancreas transplant. Transplant Proc. 1997;29:666.
6. Humar A, Kandaswamy R, Drangstveit MB, Parr E, Gruessner AG, Sutherland DE. Surgical risks and outcome of pancreas retransplants. Surgery. 2000;127:634-640.
7. Genzini T, Crescentini F, Torricelli FCM, Antunes I, Hayashi a, Kim NJ. Pancreas retransplantation: outcomes of 20 cases. Transplant Proc. 2006;38:1937.
8. LaMattina JC, Sollinger HW, Becker YT, Mezrich JD, Pirsch JD, Odorico JS. Simultaneous pancreas and kidney (SPK) retransplantation in prior SPK recipients. Clin Transplant. 2011;26:495-501.
9. Buron F, Thaunat O, Demuylder-Mischler S, et al. Pancreas retransplantation: a second chance for diabetic patients? Transplantation. 2013;95:347-352.
10. Fridell JA, Mangus RS, Powelson JA, Goble ML, Mujtaba MA, Taber TE. Late pancreas retransplantation [Internet]. 14th World Congress of the International Pancreas and Islet Transplant Association, Monterey CA. Abstract Presentation September 25, 2013. Available from: https://tech4pco.com/ipita2013/mobis/lecture/238.
11. Fertmann JM, Arbogast HP, Illner W-D, et al. Antithrombin therapy in pancreas retransplantation and pancreas-after-kidney/pancreas-transplantation-alone patients. Clin Transplant. 2011;25:E499-E508.
12. Gruessner AC, Sutherland DER. Pancreas Transplant Outcomes for United States (US) and Non-US Cases as Reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of May 2013. In: Cecka JM, Terasaki PI, editors. Clin Transpl 2003 Los Angeles: UCLA Immunogenetics Center; 2003. p. 21-51.
13. Gruessner AC, Sutherland DER, Gruessner RWG. Pancreas transplantation in the United States: a review. Curr Opin Organ Transplant. 2010;15:93-101.
14. Gruessner AC, Gruessner RWG. Pancreas transplant outcomes for United States and non United States cases as reported to the United Network for Organ Sharing and the International Pancreas Transplant Registry as of 2011. Clin Transpl. 2012:23-40.
15. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2012. Annual Data Report. 2012:45-68.
16. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg. 2001;233(4):463-501.
17. Frey DJ, Matas AJ, Gillingham KJ, et al. Sequential therapy-a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation. 1992;54(1):50-56.
18. Suszynski TM, Gillingham KJ, Rizzari MD, et al. Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. Am J Transplant. 2013;13(4):961-970.
19. Axelrod DA, Sung RS, Meyer KH, Wolfe RA, Kaufman DB. Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization. Am J Transplant. 2010;10(4):837-845.
20. Sansalone CV, Aseni P, Follini ML, et al. Early pancreas retransplantation for vascular thrombosis in simultaneous pancreas-kidney transplants. Transplant Proc. 1998;30(2):253-254.
21. Seal J, Selzner M, Marquez M, et al. Pancreas re-transplantation graft survival is comparable to primary pancreas after kidney transplantation. Am J Tranpslantation. 2013;13:176.
22. Sansalone CV, Maione G, Rossetti O, et al. Pancreas retransplantation: ideal timing and early and late results. Transplant Proc. 2006;38:1153-1155.
23. Magee JC, BarrML, BasadonnaGP, et al. Repeat organ transplantation in the United States, 1996-2005. Am J Transplant. 2007;7(5 Pt 2):1424-1433.
24. Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57:1349-1354.